Publications by Izquierdo, Miguel

2020

Sonnenblick, Amir; Agbor-tarh, Dominique; de Azambuja, Evandro; Hultsch, Susanne; Izquierdo, Miguel; Liu, Minetta; Pruneri, Giancarlo; Harbeck, Nadia; Piccart, Martine; Moreno-Aspita, Alvaro; Granit, Roy Zvi; Rouas, Ghizlane; Fahoum, Ibrahim; Sotiriou, Christos (2020): STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial. In: International Journal of Cancer, Vol. 148, No. 6: pp. 1529-1535

2019

Di Cosimo, Serena; Triulzi, Tiziana; Pizzamiglio, Sara; De Cecco, Loris; de Azambuja, Evandro; Fumagalli, Debora; Putzai, Lajos; Harbeck, Nadia; Izquierdo, Miguel; de la Pena, Lorena; Daidone, Maria Grazia; Huober, Jens; Gori, Stefania; Cinieri, Saverio; Torri, Valter; Baselga, Jose; Piccart, Martine; de Braud, Filippo G.; Apolone, Giovanni; Verderio, Paolo; Tagliabue, Elda (2019): The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study. In: European Journal of Cancer, Vol. 118: pp. 1-9

2018

Ponde, Noam; Bradbury, Ian; Lambertini, Matteo; Ewer, Michael; Campbell, Christine; Ameels, Helene; Zardavas, Dimitrios; Di Cosimo, Serena; Baselga, Jose; Huober, Jens; Izquierdo, Miguel; Fumagalli, Debora; Bozovic-Spasojevic, Ivana; Maetens, Marion; Harbeck, Nadia; Pusztai, Lajos; Berghorn, Michael; Im, Young-Hyuck; Ruiz Borrego, Manuel; Chen, Dar-Ren; Rodeheffer, Richard; Piccart, Martine; Suter, Thomas; Azambuja, Evandro de (2018): Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06). In: Breast Cancer Research and Treatment, Vol. 168, No. 3: pp. 631-638